Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark

Epidemiology and Infection

Volumn 142, Issue 4, 2014, Pages 729-737

  Ronn P F ^a   Dalby, T ^a   Simonsen, J ^a   Jorgensen C S ^a   Linneberg, A ^b   Krogfelt, K A ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b Research Centre for Prevention and Health   (Denmark)

Author keywords

Bordetella pertussis; epidemiology; serology

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGE; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DENMARK; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERTUSSIS; RISK FACTOR; SEROPREVALENCE; AGE DISTRIBUTION; ANTIBODY SPECIFICITY; BACTERIAL TRANSMISSION; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; INCIDENCE; INFECTION RISK; PUBLIC HEALTH; SEROEPIDEMIOLOGY; SEROLOGY; VULNERABLE POPULATION; ADOLESCENT; BLOOD; BORDETELLA PERTUSSIS; EPIDEMIOLOGY; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; WHOOPING COUGH; YOUNG ADULT;

EID: 84901699395     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813002446     Document Type: Article

References (44)

1. Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatric Infectious Disease Journal 2005; 24: S104-S108.
2. Pebody RG, et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiology and Infection 2005; 133: 159-171.
3. Guiso N, Liese J, Plotkin S. The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, 14-15April 2010. Human Vaccines 2011; 7: 481-488.
4. Zepp F, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infectious Diseases 2011; 11: 557-570.
5. Quinn HE, McIntyre PB. Pertussis epidemiology in Australia over the decade 1995-2005-trends by region and age group. Communicable Diseases Intelligence Quarterly Report 2007; 31: 205-215.
6. Euvac.Net. Pertussis surveillance report 2003-2007: European Centre for Disease Prevention and Control (ECDC); 2009.
7. Dalby T, Christiansen AH, Andersen PH. Whooping cough 2008. EPI-NEWS, 2009, No. 44 (http://www.ssi. dk/English/News/EPI-NEWS.aspx).
8. Dalby T, Christiansen AH, Andersen PH. Whooping cough 2009. EPI-NEWS, 2010, No. 44 (http://www.ssi. dk/English/News/EPI-NEWS.aspx).
9. Dalby T, Knudsen LK, Andersen PH. Whooping cough 2010. EPI-NEWS, 2011, No. 43-44 (http://www.ssi.dk/English/News/EPI-NEWS.aspx).
10. Dalby T, et al. Whooping cough 2007. EPI-NEWS, 2008, No. 42-43 (http://www.ssi.dk/English/News/EPINEWS. aspx).
11. Dalby T, et al. Laboratory diagnosed whooping cough 2005 and 2006. EPI-NEWS, 2007, No. 42-43 (http://www.ssi.dk/English/News/EPI-NEWS.aspx).
12. Pedersen T, Fisker N, Andersen PH. Neuroborreliosis 1994-2004. EPI-NEWS, 2005, No. 33 (http://www.ssi. dk/English/News/EPI-NEWS.aspx).
13. Wiley KE, et al. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine 2013; 31: 618-625.
14. Yih WK, et al. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. Journal of Infectious Diseases 2000; 182: 1409-1416.
15. de Melker HE, et al. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. Journal of Infection 2006; 53: 106-113.
16. Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatric Respiratory Review 2008; 9: 201-211.
17. Wendelboe AM, et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatric Infectious Disease Journal 2005; 24: S58-S61.
18. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet 2006; 367: 1926-1936.
19. Guiso N, et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. European Journal of Clinical Microbiology and Infectious Diseases 2011; 30: 307-312.
20. Dalby T. Whooping cough serology: Development of a diagnostic method and seroprevalence in Denmark (PhD Thesis). Copenhagen: University of Copenhagen; 2010. 70 pp.
21. Hoffait M, et al. Pertussis knowledge, attitude and practices in European health care professionals in charge of adult vaccination. Human Vaccines 2011; 7: 197-201.
22. Thuesen BH, et al. Cohort Profile: The Health 2006 cohort, Research Centre for Prevention and Health. International Journal of Epidemiology 2013: 1-8.
23. Dalby T, et al. Problem solved: a modified enzymelinked immunosorbent assay for detection of human antibodies to pertussis toxin eliminates false-positive results occurring at analysis of heat-treated sera. Diagnostic Microbiology and Infectious Disease 2009; 63: 354-360.
24. de Melker HE, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. Journal of Clinical Microbiology 2000; 38: 800-806.
25. Dalby T, Harboe ZB, Krogfelt KA. Seroprevalence of pertussis in Danish patients with cough of unknown etiology. Clinical Vaccine Immunology 2010; 17: 2016-2023.
26. de Greeff SC, et al. Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples. Clinical and Vaccine Immunology 2012; 19: 1452-1456.
27. Statens Serum Institut (SSI). (http://www.ssi.dk/Vaccination/ Boernevaccination.aspx) Accessed 18 December 2012.
28. Dalby T, et al. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. Journal of Medical Microbiology 2010; 59: 1029-1036.
29. Serfling RE. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Reports 1963; 78: 494-506.
30. Simonsen J, et al. Estimation of incidences of infectious diseases based on antibody measurements. Statistics in Medicine 2009; 28: 1882-1895.
31. de Greeff SC, et al. Seroprevalence of pertussis in The Netherlands: evidence for increased circu lation of Bordetella pertussis. PLoS One 2010; 5: e14183.
32. Rendi-Wagner P, et al. The seroepidemiology of Bordetella pertussis in Israel - estimate of incidence of infection. Vaccine 2010; 28: 3285-3290.
33. Kretzschmar M, Teunis PFM, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Medicine 2010; 7: e1000291.
34. Liu BC, et al. Pertussis in older adults: prospective study of risk factors and morbidity. Clinical Infectious Diseases 2012; 55: 1450-1456.
35. Addis ME, Mahalik JR. Men, masculinity, and the contexts of help seeking. American Psychologist 2003; 58: 5-14.
36. Wendelboe AM, et al. Transmission of Bordetella pertussis to young infants. Pediatric Infectious Disease Journal 2007; 26: 293-299.
37. Flory JH, et al. Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults. Epidemiology and Infection 2009; 137: 717-726.
38. Charland KM, et al. Socio-economic disparities in the burden of seasonal influenza: the effect of social and material deprivation on rates of influenza infection. PLoS One 2011; 6: e17207.
39. Arcavi L, Benowitz NL. Cigarette smoking and infection. Archives of Internal Medicine 2004; 164: 2206-2216.
40. Huttunen R, Heikkinen T, Syrjanen J. Smoking and the outcome of infection. Journal of Internal Medicine 2011; 269: 258-269.
41. Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis. Epidemiology and Infection 2010; 138: 1789-1795.
42. Capili CR, et al. Increased risk of pertussis in patients with asthma. Journal of Allergy and Clinical Immunology 2012; 129: 957-963.
43. Anderson P, Stellfeld M. Childhood vaccination programme modified. EPI-NEWS, 2003, No. 26-33 (http://www.ssi.dk/English/News/EPI-NEWS.aspx).
44. Thierry-Carstensen B, et al. A randomised, doubleblind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults. Vaccine 2012; 30: 5464-5471.